Opc,

I would pay to watch somebody answer your questions. I suspect though you would have all of them pleading the fifth and hiding behind the veil of corporate responsibility. Many of the questions can not be answered without exposing ongoing discussions with potential partners of which I beleive there are many but only a couple good fits for this drug.

The questions regarding the financing and the hit all investors save one have taken should be answered quickly to reinforce investor confidence. I am constantly amazed in the 4 years I have been invested in MannKind there has been no good news. Even a blind squirrel finds an acorn every now and then!

Swing